The IPO Buzz: Required Reading

Two of this week’s nine IPOs have attracted some investors’ interest. One company is a spinoff providing a platform to streamline cloud software development and the other is developing next-generation cancer therapies to boost patients’ immune systems. All you need to know can be found in their prospectuses. For that matter, if you read the prospectus for each of the rest of this week’s IP..

Read more April 15, 2018

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Alzheon ALZH Citigroup/Piper Jaffray 5.0 13.00 15.00 $ 70.0 mil 4/16/2018 Day-to-Day S/O S/O
Mereo BioPharma Group plc MREO Cowen/ BMO Capital Markets/ RBC Capital Markets 2.8 17.62 17.62 $ 49.9 mil 4/19/2018 Day-to-Day S/O S/O
MorphoSys AG MOR Goldman Sachs/ J.P. Morgan/ Leerink Partners 8.3 25.04 25.04 $ 207.8 mil 4/19/2018 S/O S/O
Read more

Last 100 IPOs - April 19, 2018

Number of IPOs priced : 100
Number Up: 56
Number Down: 42
Number Unchanged: 2
Percentage Change From Issue Price: 17.68%
Percentage Change for The Nasdaq Composite 13.59%

2018 IPO Scorecard - April 19, 2018

Number of IPOs priced (Excluding 12 units) : 47
Number Up: 20
Number Down: 26
Number Unchanged: 1
Total Return From Issue Price: 2.67%
The Nasdaq Composite Index YTD % Change 5.68%